Sort
8,912 grants matching “sars cov 2”
Human T cell-mediated immunity to viruses in tissues and circulation
$388,769Donna L Farber · Columbia University Health Sciences · U19 · FY2023 · AI
Development and characterization of engineered therapeutic antibodies against SARS-CoV-2
$388,750Gaya K. Amarasinghe · Washington University · R01 · FY2023 · AI
DFU Clinical Research Unit
$388,652Rodica Pop-Busui · University Of Michigan At Ann Arbor · U01 · FY2020 · DK
Weather extremes, natural disasters, and health outcomes among vulnerable older adults: New improvements on exposure assessment, disparity identification, and risk communication strategies
$388,608Shao Lin · State University Of New York At Albany · R01 · FY2022 · AG
Mechanism of the short- and long-term effects of COVID-19-induced Alarmins on hematopoietic stem and progenitor cells.
$388,500Ying Liang · University Of Kentucky · R01 · FY2022 · DK
SARS Replicase Proteins in Pathogenesis and Replication
$388,202Mark R Denison · Univ Of North Carolina Chapel Hill · P01 · FY2006 · AI
Center for dynamic RNA epitranscriptomes - Covid 19 Supplement Version 2
$388,014Chuan He · University Of Chicago · RM1 · FY2020 · HG
Addressing community-level influences of HIV and COVID-19 disparities among people with HIV
$387,882Diana Montserrat Sheehan · Florida International University · U54 · FY2024 · MD
Technologies and Resources for Core Laboratories
$387,703Laura F Gibson · West Virginia University · U54 · FY2022 · GM
Adducin, actin cytoskeleton and cognitive impairments
$387,500Fan Fan · University Of Mississippi Med Ctr · R01 · FY2022 · AG
Adducin, actin cytoskeleton and cognitive impairments
$387,500Jan Michael Williams · University Of Mississippi Med Ctr · R01 · FY2023 · AG
Antibody Core
$387,318Ali Hassan Ellebedy · Icahn School Of Medicine At Mount Sinai · P01 · FY2025 · AI
Animal Core
$387,318Stephen Mark Tompkins · Icahn School Of Medicine At Mount Sinai · P01 · FY2024 · AI
Innate immunity against viral infection in intestinal epithelial cells of C. elegans
$387,195Emily R Troemel · University Of California, San Diego · R01 · FY2023 · AI
Innate immunity against viral infection in intestinal epithelial cells of C. elegans
$386,805Emily R Troemel · University Of California, San Diego · R01 · FY2024 · AI
Virus-Like Particle Vaccine for SARS-CoV
$386,641Raphael Paul Viscidi · Johns Hopkins University · R01 · FY2010 · AI
Development of peptide-based vaccine against SARS-CoV
$386,576Gang Liu · Institute Of Materia Medica · U01 · FY2007 · AI
A knowledge map to find Alzheimer's disease drugs
$386,555Olivier Lichtarge · Baylor College Of Medicine · R01 · FY2020 · AG
Real-world impact of the COVID-19 pandemic in people with multiple sclerosis
$386,508Zongqi Xia · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · NS
Robotic Lung Ultrasound for Triage of COVID-19 Patients in a Resource-Limited Environment
$386,461Haichong Zhang · Worcester Polytechnic Institute · DP5 · FY2020 · OD
Biochemistry of SARS-CoV-2 Spike Protein and its Ocular Surface Membrane Receptor
$386,457T. Michael Redmond · National Eye Institute · ZIA · FY2024 · EY
Harmonized Diagnostic Assessment of Dementia (DAD) for Longitudinal Aging Study of India (LASI)-Genomic study
$386,374Jinkook Lee · University Of Southern California · U01 · FY2023 · AG
Characterization of the SARS-CoV frameshift signal
$386,308Jonathan D. Dinman · Univ Of Maryland, College Park · R01 · FY2007 · AI
Ligand-mediated, vehicle-free delivery of small RNAs
$386,276Andrea L Kasinski · Purdue University · R01 · FY2023 · CA
Photonics-based Fluorescence Imaging for Research, Diagnostics, and Pathology
$386,250Joseph R. Lakowicz · University Of Maryland Baltimore · R35 · FY2024 · GM